Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Canopy Growth Continues Its March To Expansion In Pot Sector

Published 2019-03-21, 12:12 p/m
Updated 2020-09-02, 02:05 a/m

It’s been a busy week for Canopy Growth Corp (TO:WEED). In the last three days, the Canadian marijuana producer has made three announcements that expands its presence in the rapidly developing cannabis sector. And it’s only Thursday.

This morning, the Ontario-based pot producer announced the acquisition of AgriNextUSA, an American-based hemp producer. The deal is being touted as a move to accelerate Canopy Growth’s expansion into the now-legal hemp market south of the border. Hemp is now a legal substance in the U.S. since the passage last December of the U.S. Farm Bill.

“The United States is the next stop on Canopy Growth’s desired path to becoming a leading revenue-generating company focused on all aspects of cannabinoids and their potential,” Bruce Linton, co-CEO and chairman of Canopy Growth, said in a statement.

Linton pointed to AgriNextUSA’s CEO Geoff Whaling, a high-profile pioneer in the move to legalize hemp in the U.S., as being a key figure in the deal.

“By collaborating with a pioneer like Geoff, who has been involved with our team since our earliest days in 2013, we will aim to turn hemp supplied by American farmers into a wide range of products.”

According to observers, hemp is positioned to disrupt several industries – everything from food to cosmetics, and textiles to wellness products.

“Hemp has the potential to become a multi-billion-dollar industry that will boost the American economy for generations to come,” Whaling said.

The deal will see Canopy Growth invest between US$100 million and US$150 million at its proposed New York hemp operations.

Yesterday, Canopy Growth announced a multi-year agreement with British-Columbia-based HollyWeed North Cannabis Inc. to process dried cannabis in a facility in Victoria to produce high-quality oil and resin. This will help Canopy better meet the demand for new CDB-infused edible products, expected to hit Canadian markets later this year when they are legalized.

And on Tuesday, Canopy Growth trumpeted a new agreement to extend its partnership with OG DNA Genetics, a globally recognized cannabis brand, to bring the company’s reputed genetics into the European market. Details of the expansion plan were not disclosed, but the deal extends the partnership through to 2024.

Last month, Canopy Growth reported its third quarter financial results for the period that ended Dec. 31, 2018. Net revenue was C$83 million, up 282 percent from the year before. Total product sales were also up 334 percent. Adjusted EBITDA third quarter results showed a loss of C$75.1 million compared with a loss of C$5.7 million in the same period the year before.

Canopy Growth stock today are trading at $61.88, down 0.67 percent on the day. Yesterday, shares hit a mark of $64.37 before closing at $62.30. The company has a market cap of $21.13 billion.

Latest comments

How about you include Why is Constellations Brands SP has lost 100% of its market price. It is back where it started the day it invested in CGC. As a share holder of Constellations Brands I would like to see 50% of them shares unloaded. I want my money back.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.